BBT-012 (Bolder BioTechnology)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameBBT-012 (Bolder BioTechnology)
Drug Alias Namelong-acting alpha interferonBBT-012
ClassificationBiologics
Mechanisms of ActionVirus replication inhibitors
TargetsNot applicable
Therapy Area/IndicationsHepatitis CHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBolder Biotechnology
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBolder Biotechnology
Active IndicationsN/A
Inactive IndicationsHepatitis CHepatitis B

Other Information

ATC CodeN/A
Related LinksN/A